Brigitte S.
- Country
- Germany
- Department
- Klinik für Angeborene Herzfehler und Pädiatrische Kardiologie
Research Overview
- A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study with Open-Label Extension Period to Assess the Efficacy and Safety of Selexipag as Add-On Treatment to Standard of Care in Children Aged ≥2 to <18 years with Pulmonary Arterial Hypertension
- A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants with Heart Failure due to Systemic Left Ventricular Systolic Dysfunction (VALOR)
- Safety and Pharmacodynamics of Intravenous Cangrelor in Pediatric Patients with Congenital Heart Disease Undergoing Percutaneous Vascular Procedures
Data & Insights
Has run more than one trial at 31 of 103 partner sites.
Specializations
Pediatric Cardiology
The investigator specializes in treating heart failure in pediatric patients, with particular focus on conditions affecting left ventricular systolic dysfunction. Their research extends to innovative therapeutic approaches for managing cardiac conditions in children.
- Systemic heart failure management
- Ventricular dysfunction therapy
- Pediatric cardiac care
Their work encompasses evaluating new therapeutic agents for improving cardiac function in young patients.
Pulmonary Medicine
The investigator focuses on treating pulmonary arterial hypertension (PAH) in pediatric populations. Their expertise includes developing treatment strategies for children aged 2 to 18 years with complex pulmonary conditions.
- PAH treatment optimization
- Standard of care enhancement
- Disease progression management
Their research involves evaluating novel therapeutic approaches for pediatric pulmonary hypertension.
Infectious Disease Prevention
The investigator works in preventing respiratory syncytial virus (RSV) infections in vulnerable pediatric populations. Their focus includes protecting infants and children at elevated risk for severe RSV disease.
- RSV prevention strategies
- High-risk infant protection
- Preventive therapy evaluation
Their expertise extends to assessing new preventive treatments for respiratory infections in pediatric patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.